ReviewRadiology2023
PI-RADS: Where Next?
Review in Radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.
- Diagnostic performance of ADC and ADCratio in MRI-based prostate cancer assessment: A systematic review and meta-analysis.European radiology · 2025Pooled it
- Present status of prostate cancer diagnosis, limitations, challenges, and future endeavors.Annals of medicine · 2026Review
- Diagnostic value of intravoxel incoherent motion-based virtual MR elastography for differentiating prostate cancer from benign prostate lesion.Abdominal radiology (New York) · 2026Article
- AI-Assisted Prostate Cancer Diagnosis Using Biparametric MRI and PI-RADS v2.1: Performance Comparison Between Novice-Level and Experienced Readers.Journal of magnetic resonance imaging : JMRI · 2026Article
- Multicentre evaluation of artificial intelligence risk classification for detection of clinically significant prostate cancer on biparametric MRI.European radiology · 2026Article
- Detecting clinically significant prostate cancer with a distributed parameter model based on quantitative dynamic contrast-enhanced magnetic resonance imaging.Quantitative imaging in medicine and surgery · 2026Article
- AI-based prostate volume estimation from multi-planar MRI under variable acquisition protocols.European journal of radiology open · 2026Article
- Evaluating the impact of reader experience on PI-RADS 3 of version 2.1 scoring concordance in multiparametric prostate MRI: a single-center analysis.Abdominal radiology (New York) · 2026Article
- Non-invasive diagnosis strategy integrating PSMA PET/CT and mpMRI for patients with suspected prostate cancer: a multi-center study.BMC medicine · 2026Article
- Development and Validation of an AI-Assisted Predictive Model Integrating R2* Mapping and Clinical Indicators for Clinically Significant Prostate Cancer.Cancer medicine · 2026Article
- Prospective validation of an AI software for detecting clinically significant prostate cancer on biparametric MRI.Insights into imaging · 2026Article
- Zero-Shot PI-RADS Version 2.1 Scoring with ChatGPT-4 Turbo and Llama 3: Diagnostic Performance and Agreement with Abdominal Radiologists.Radiology. Imaging cancer · 2026Article
- MRI-based habitat radiomics analysis for predicting clinically significant prostate cancer: a retrospective dual-center study.Frontiers in oncology · 2026Article
- Positive predictive value of the prostate imaging reporting and data system combined with single related indicators in prostate cancer across different prostate zones.Frontiers in oncology · 2026Article
- Reliability of Negative Prostate MRI for Biopsy Decision-Making in the Male Han Chinese Population.Prostate cancer · 2026Article
- Current state of the art of new prostate MRI technologies and potential future developments.BJR open · 2026Review
- Simulating workload reduction with an AI-based prostate cancer detection pathway using a prediction uncertainty metric.European radiology · 2025Article
- Imaging in focal therapy: advanced ultrasound imaging and mpMRI-a comprehensive review.Prostate cancer and prostatic diseases · 2025Review
- An MRI-pathology foundation model for noninvasive diagnosis and grading of prostate cancer.Nature cancer · 2025Article
- Combination of prostate cancer antigen 3 (PCA3), sarcosine, glypican-1 (GPC1), urokinase plasminogen activator receptor (uPAR), and thymidine kinase 1 (TK1), and T2WI and DWI radiomics model for distinguishing benign prostatic hyperplasia, prostate cancer, and prostatitis.Journal of medical biochemistry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Prostate MRI plays an important role in the clinical management of localized prostate cancer, mainly assisting in biopsy decisions and guiding biopsy procedures. The Prostate Imaging Reporting and Data System (PI-RADS) has been available to radiologists since 2012, with the most up-to-date and actively used version being PI-RADS version 2.1. This review article discusses the current use of PI-RADS, including its limitations and controversies, and summarizes research that aims to improve future iterations of this system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.